| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |